A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies

Overview of attention for article published in Journal of Translational Medicine, March 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 tweeter

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 61 Mendeley

Summary Twitter Dimensions citations

So far, Altmetric has seen 1 tweet from an account with 78 followers.

A phase I study of high-dose rosuvastatin with standard dose erlotinib in… https://t.co/6F1uVoh92L #JTransMed

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity.